Home / Medicine / Befunginum

Befunginum

Recorded active ingredients: Cobalt chloride, Fungi betulini extract

Based on a snapshot of pillintrip.com listings. Country listings do not confirm current availability or registration. Sources and limitations · How matching works.

Countries
Drug Actions

Medicines with the same recorded active ingredients

These listings match the full ingredient set recorded for Befunginum. Strength, dosage form and route may differ or be missing. This does not establish interchangeability; confirm a suitable product with a pharmacist.

Contraindications

Hypersensitivity.

Undesirable effects

Allergic reactions.

Therapeutic indications

Diseases of the gastrointestinal tract (chronic gastritis, gastrointestinal dyskinesia with atony phenomena, gastric ulcer), psoriasis, tumor pathology (to improve the general condition of patients).

Pharmacotherapeutic group

  • General ionizing agents and adaptogens in combinations
  • Other metabolites in combinations

Pharmacodynamic properties

The effect is determined by the effect of biologically active substances included in the preparation (polysaccharides, humin-like chagic acid, organic acids, trace elements, including manganese and cobalt, hormonal, etc.) involved in the regulation of tissue metabolism. It suppresses the development of tumor cells (due to its influence on free radical processes).

Special precautions for storage

In a cool, dark place.

Keep out of reach of children.

Shelf life of the drug Befungin3 года.

Do not use after the expiration date indicated on the package.

Instructions for medical use Бефунгин - инструкция по медицинскому применению - РУ № ЛСР-007839/09 от 2009-10-06
Бефунгин - инструкция по медицинскому применению - РУ № ЛП-001918 от 2017-11-30
Бефунгин - инструкция по медицинскому применению - РУ № ЛСР-008766/09 от 2009-11-02

Nature and contents of container

Liquid obtained from fungal growths of the birch fungus chaga. 100 g of the liquid also contains 0.175 g of cobalt chloride or 0.2 g of cobalt sulfate, in 100 ml vials.

Nosological classification (ICD-10)

  • C15-C26 Malignant neoplasms of the digestive system
  • K25 Stomach ulcer
  • K26 Duodenal ulcer
  • K29. 5 Chronic gastritis, unspecified
  • K31. 9 Stomach and duodenal disease, unspecified
  • L40 Psoriasis

Dosage (Posology) and method of administration

Inside, 30 minutes before meals. Before use, the contents of the bottle are shaken, diluted for 3 hours.2 tablespoons of the drug in 150 ml of warm boiled water. Take 1 tbsp.spoon 3 times a day for 3-5 months. If necessary, the treatment courses are repeated with intervals of 7-10 days.

ATC - Anatomical and therapeutic chemical classification

A13A General Ionizing agents

Listed in 1 countries